Month: November 2023

Despite some market pessimism surrounding next year and the often prophesied recession, there are still oversold marijuana stocks to buy that offer great value. The companies on this list benefit from the emerging health benefits of these plants and the continued liberalization of what were once illicit drugs in the U.S. I foresee a rise
0 Comments
In this article UBSG-CH Follow your favorite stocksCREATE FREE ACCOUNT Despite indicators like U.S. credit card debt pointing toward financial and economic pressures, another global financial crash is not imminent, UBS chief U.S. economist Jonathan Pingle believes. U.S. credit card debt soared to $1.08 trillion in the third quarter of 2023, data from the Federal
0 Comments
A new inflation report is out, and markets have reacted positively. Headline U.S. inflation essentially stalled in October, while the core consumer price index, which excludes food and energy costs, increased 0.2% from September. Positive indications that inflation is indeed coming down could incite a broader market rally as the year comes to a close.
0 Comments
Qualcomm (NASDAQ:QCOM) is a leading wireless technology and semiconductors business I have written positively about, primarily citing its relatively cheap valuation and successful foray into 5G. However, the QCOM stock’s disappointing earnings results this year, coupled with one of its biggest markets, China, moving to develop a vibrant domestic semiconductor industry, have made me reconsider. QCOM’s
0 Comments
Ahead of what could be significant uncertainties in the market, investors may be better served with cutting-edge biotech stocks. Fundamentally, the reasoning centers on relative insulation. Of course, no sector is ever fully insulated from the equity sector’s ebb and flow. And even established blue chips may suffer volatility if the major indices print red
0 Comments
The stock market is at a crossroads. The indexes had a rough autumn as higher interest rates, inflation and mounting geopolitical crises cast a negative tone. However, stocks have shown a strong pulse recently, with growth-focused companies leading the charge higher. However, the rally still appears tenuous, especially as the Federal Reserve sends mixed messages
0 Comments
Souders Financial Advisors reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 4.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,003 shares of the biopharmaceutical company’s stock after selling 3,143 shares during the quarter. Souders Financial Advisors’ holdings in Pfizer were
0 Comments